Trial Profile
An Open-label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetics of HIP1403 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 24 Oct 2016 New trial record